RBM12B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.944400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.072800E-01
Normal-vs-Stage2
5.107400E-01
Normal-vs-Stage3
2.549200E-01
Normal-vs-Stage4
6.801800E-01
Stage1-vs-Stage2
5.993400E-01
Stage1-vs-Stage3
1.316180E-02
Stage1-vs-Stage4
9.539600E-01
Stage2-vs-Stage3
5.005700E-02
Stage2-vs-Stage4
8.011600E-01
Stage3-vs-Stage4
3.097800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.955600E-01
Normal-vs-AfricanAmerican
3.227800E-01
Normal-vs-Asian
1.891850E-01
Caucasian-vs-AfricanAmerican
9.702600E-01
Caucasian-vs-Asian
5.755800E-01
AfricanAmerican-vs-Asian
7.587400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.977600E-01
Normal-vs-Female
4.947600E-01
Male-vs-Female
9.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.264000E-01
Normal-vs-Age(41-60Yrs)
6.212000E-01
Normal-vs-Age(61-80Yrs)
4.551200E-01
Normal-vs-Age(81-100Yrs)
3.871000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.096000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.716200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.240000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.379550E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.142200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.262400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.651400E-01
Normal-vs-Daily Drinker
8.168400E-02
Normal-vs-Weekly Drinker
1.811230E-01
Normal-vs-Occasional Drinker
5.243000E-01
Normal-vs-Social Drinker
5.666000E-01
Non Drinker-vs-Daily Drinker
4.702200E-01
Non Drinker-vs-Weekly Drinker
9.489200E-01
Non Drinker-vs-Occasional Drinker
5.944600E-01
Non Drinker-vs-Social Drinker
3.750600E-01
Daily Drinker-vs-Weekly Drinker
5.123200E-01
Daily Drinker-vs-Occasional Drinker
2.461200E-01
Daily Drinker-vs-Social Drinker
1.339800E-01
Weekly Drinker-vs-Occasional Drinker
6.914200E-01
Weekly Drinker-vs-Social Drinker
4.580200E-01
Occasional Drinker-vs-Social Drinker
7.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.911450E-01
Normal-vs-Grade 2
2.675600E-02
Normal-vs-Grade 3
4.960000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.361800E-01
Grade 1-vs-Grade 3
1.095800E-01
Grade 1-vs-Grade 4
1.911450E-01
Grade 2-vs-Grade 3
1.834380E-01
Grade 2-vs-Grade 4
2.675600E-02
Grade 3-vs-Grade 4
4.960000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.041800E-01
Normal-vs-NonDiabetic
4.777400E-01
Diabetic-vs-NonDiabetic
1.822960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.499200E-01
Normal-vs-NoPancreatitis
4.645400E-01
Pancreatitis-vs-NoPancreatitis
8.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.185590E-01
Normal-vs-N1
5.107600E-01
N0-vs-N1
5.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.629600E-01
Normal-vs-TP53-NonMutant
5.436200E-01
TP53-Mutant-vs-TP53-NonMutant
1.861980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
